Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS)
CNY 13.74
(3.85%)
CNY 13.74
(3.85%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 612.59 Million CNY | 3.06% |
| 2022 | 594.41 Million CNY | 2.54% |
| 2021 | 579.68 Million CNY | 27.5% |
| 2020 | 454.66 Million CNY | 13.62% |
| 2019 | 400.17 Million CNY | 33.84% |
| 2018 | 299 Million CNY | 104.2% |
| 2017 | 146.42 Million CNY | 2.06% |
| 2016 | 143.47 Million CNY | -12.45% |
| 2015 | 163.86 Million CNY | -11.76% |
| 2014 | 185.71 Million CNY | 18.7% |
| 2013 | 156.45 Million CNY | -0.2% |
| 2012 | 156.76 Million CNY | 25.73% |
| 2011 | 124.68 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 791.94 Million CNY | 11.23% |
| 2024 Q1 | 659.73 Million CNY | 7.69% |
| 2024 Q2 | 711.97 Million CNY | 7.92% |
| 2023 Q1 | 648.07 Million CNY | 9.03% |
| 2023 Q4 | 612.59 Million CNY | -12.6% |
| 2023 Q3 | 700.92 Million CNY | 6.7% |
| 2023 Q2 | 656.88 Million CNY | 1.36% |
| 2023 FY | 612.59 Million CNY | 3.06% |
| 2022 Q4 | 594.41 Million CNY | -13.35% |
| 2022 FY | 594.41 Million CNY | 2.54% |
| 2022 Q3 | 685.98 Million CNY | 8.35% |
| 2022 Q2 | 633.13 Million CNY | 9.54% |
| 2022 Q1 | 577.98 Million CNY | -0.29% |
| 2021 Q2 | 481.58 Million CNY | -2.84% |
| 2021 FY | 579.68 Million CNY | 27.5% |
| 2021 Q1 | 495.69 Million CNY | 9.02% |
| 2021 Q4 | 579.68 Million CNY | 8.83% |
| 2021 Q3 | 532.63 Million CNY | 10.6% |
| 2020 Q1 | 378.66 Million CNY | -5.37% |
| 2020 Q2 | 382.22 Million CNY | 0.94% |
| 2020 Q3 | 431.94 Million CNY | 13.01% |
| 2020 FY | 454.66 Million CNY | 13.62% |
| 2020 Q4 | 454.66 Million CNY | 5.26% |
| 2019 Q3 | 432.24 Million CNY | 9.73% |
| 2019 Q1 | 365.38 Million CNY | 22.2% |
| 2019 FY | 400.17 Million CNY | 33.84% |
| 2019 Q4 | 400.17 Million CNY | -7.42% |
| 2019 Q2 | 393.9 Million CNY | 7.81% |
| 2018 Q2 | 261.76 Million CNY | 58.73% |
| 2018 FY | 299 Million CNY | 104.2% |
| 2018 Q4 | 299 Million CNY | 1.97% |
| 2018 Q3 | 293.22 Million CNY | 12.02% |
| 2018 Q1 | 164.9 Million CNY | 12.62% |
| 2017 Q3 | 147.49 Million CNY | 2.2% |
| 2017 Q2 | 144.32 Million CNY | 7.03% |
| 2017 Q1 | 134.84 Million CNY | -6.01% |
| 2017 FY | 146.42 Million CNY | 2.06% |
| 2017 Q4 | 146.42 Million CNY | -0.73% |
| 2016 Q4 | 143.47 Million CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 FY | 143.47 Million CNY | -12.45% |
| 2015 FY | 163.86 Million CNY | -11.76% |
| 2014 Q4 | 185.71 Million CNY | 0.0% |
| 2014 Q1 | 162.71 Million CNY | 0.0% |
| 2014 FY | 185.71 Million CNY | 18.7% |
| 2014 Q2 | 162.71 Million CNY | 0.0% |
| 2013 FY | 156.45 Million CNY | -0.2% |
| 2012 FY | 156.76 Million CNY | 25.73% |
| 2011 FY | 124.68 Million CNY | 0.0% |